Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma

BACKGROUND: Asthma is a disease with high cost for the National Health Service. Two of the most recent LABA/ICS combinations for persistent bronchial asthma are Beclomethasone dipropionate/Formoterol (B/F) delivered via the Nexthaler device and Fluticasone furoate/Vilanterol (F/V) delivered via the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Multidiscip Respir Med
Hlavní autoři: Dal Negro, Roberto W., Distante, Chiara, Bonadiman, Luca, Turco, Paola, Iannazzo, Sergio
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4893834/
https://ncbi.nlm.nih.gov/pubmed/27275384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40248-016-0055-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky